PRINCETON, N.J., March 29, 2011 /PRNewswire/ -- Abbott announced today it has received clearance from the U.S. Food and Drug Administration to begin marketing the i-STAT® 1 Wireless handheld, a new ...

Abbott announced it has received clearance from the US Food and Drug Administration to begin marketing the i-STAT 1 wireless handheld, a new wireless version of the i-STAT point of care testing system ...

The FDA cleared Abbott's i-STAT 1 Wireless point-of-care blood analyzer last week, marking the fourth wireless-enabled medical device to receive FDA clearance so far this year. Ascom, Monica ...

East Windsor, New Jersey, October 2, 2007 — Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted waived status under the Clinical Laboratory Improvement Amendements of ...

PRINCETON, N.J., Jan. 19 Abbott announced todaythat the U.S. Food and Drug Administration (FDA) has granted waived statusunder the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for ...

Abbott Laboratories ABT recently received Health Canada approval for the i-STAT TBI test cartridge for use with whole blood. It is designed to help clinicians assess suspected concussion at the ...

A medical staff conducts a blood test for a patient using Abbott's i-STAT system at Leishenshan Hospital in Wuhan, Hubei province. [Photo provided to China Daily] Using advanced medical technology and ...

Abbott will develop the galectin-3 diagnostic on its i-STAT® System. BG Medicine and Abbott Laboratories are expanding their arrangement to include the development of a galectin-3 test for Abbott ...

The FINANCIAL — Women account for nearly 60 percent of visits to emergency departments (ED) in the United States. In emergency situations, it is critical for doctors to know the pregnancy status of ...